Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Mishal Qubad, Robert A. Bittner
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 17

Showing 17 citing articles:

When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis
Mishal Qubad, Gabriele Dupont, Martina Hahn, et al.
CNS Drugs (2024) Vol. 38, Iss. 9, pp. 671-696
Open Access | Times Cited: 4
Clozapine Induces Agranulocytosis via Inflammatory and Hematopoietic Cytokine Induction of the JAK–STAT Signaling Pathway: Evidence From Network Pharmacology and Molecular Docking
Ying Zhang, Ranli Li, Ximing Chen, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 1
Open Access
Determinants of patient satisfaction in clozapine users: results from the Clozapine International Consortium (CLOZIN)
Marte Z. van der Horst, Nini de Boer, Ahmet Müderrisoğlu, et al.
Schizophrenia (2025) Vol. 11, Iss. 1
Open Access
Clozapine and its protective effect on all-cause, natural, and suicide mortality in patients with schizophrenia: A nationwide cohort study in Taiwan
Wen‐Yin Chen, Pao‐Huan Chen, Chun‐Hung Pan, et al.
Schizophrenia Research (2023) Vol. 268, pp. 150-160
Closed Access | Times Cited: 10
The ever-growing case for clozapine in the treatment of schizophrenia: an obligation for psychiatrists and psychiatry
Robert A. Bittner, Andreas Reif, Mishal Qubad
Current Opinion in Psychiatry (2023) Vol. 36, Iss. 4, pp. 327-336
Open Access | Times Cited: 9
Impacts of exposure to and subsequent discontinuation of clozapine on tripartite synaptic transmission
Motohiro Okada, Kouji Fukuyama, Eishi Motomura
British Journal of Pharmacology (2024) Vol. 181, Iss. 22, pp. 4571-4592
Open Access | Times Cited: 3
Exploring clozapine use in severe psychiatric symptoms associated with autism spectrum disorder: A scoping review
André Luiz Schuh Teixeira, Olivia Sorato Bezerra, Luís Augusto Rohde, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 4, pp. 324-343
Closed Access | Times Cited: 2
Changes in psychopharmacotherapy for patients with schizophrenia in a psychiatric institution in Japan: A 12-year prescription survey pre- and post-introduction of clozapine
Kohei Kitagawa, Shusuke Uekusa, Yuki Hanai, et al.
Asian Journal of Psychiatry (2024) Vol. 96, pp. 104047-104047
Open Access | Times Cited: 1
Childhood trauma and treatment resistance in first-episode psychosis: Investigating the role of premorbid adjustment and duration of untreated psychosis
Kristin Fjelnseth Wold, Akiah Ottesen Berg, Camilla Bärthel Flaaten, et al.
Schizophrenia Research (2024) Vol. 270, pp. 441-450
Open Access | Times Cited: 1
Evidence for the Role of the Mitochondrial ABC Transporter MDL1 in the Uptake of Clozapine and Related Molecules into the Yeast Saccharomyces cerevisiae
Chrispian W. Theron, J. Enrique Salcedo-Sora, Justine M. Grixti, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 938-938
Open Access
Clozapine Toxicity Predictor: deep neural network model predicting clozapine toxicity and its therapeutic dose range
Adam Wysokiński, Joanna Dreczka
Psychiatry Research (2024) Vol. 342, pp. 116256-116256
Closed Access
Prevalence and Factors Associated with Hypersalivation in Schizophrenia Inpatients Treated with Clozapine: A Retrospective Study
Chanunnat Kitsinthopchai, Siripun Kumpeera, Apiradee Sangngarm, et al.
Hospital Pharmacy (2024)
Open Access
Phenotypic Polypharmacology Drug Discovery for CNS Applications
Alberto Ambesi‐Impiombato, Lee McDermott, Alan L. Pehrson, et al.
(2024), pp. 251-267
Closed Access
Neuroleptic Malignant Syndrome (NMS) Induced by Clozapine at a Very Low Dose
Chayan Kanti Manna, Milon Mondal
Bengal Journal of Psychiatry (2024) Vol. 29, pp. 52-55
Open Access
When, Why and How to Re-challenge Clozapine following Myocarditis
Mishal Qubad, Gabriele Dupont, Martina Hahn, et al.
(2023)
Open Access | Times Cited: 1
Antipsychotika
Matthias J. Müller, Otto Benkert
Springer eBooks (2023), pp. 283-488
Closed Access | Times Cited: 1
Author's Reply. RE: Longitudinal effect of clozapine-associated sedation on motivation in schizophrenia: naturalistic longitudinal study
Noham Wolpe, Shanquan Chen, Brian Kirkpatrick, et al.
The British Journal of Psychiatry (2023) Vol. 223, Iss. 1, pp. 336-337
Open Access
Page 1

Scroll to top